EpiPen Competitor Auvi-Q Will Return in February, but It'll Cost Insurance Companies Big Bucks

EpiPen Competitor Auvi-Q Will Return in February, but It'll Cost Insurance Companies Big Bucks

Odds of Surgery Partners' Takeout Grow

Odds of Surgery Partners' Takeout Grow

GNC Plummets, Mallinckrodt Regains Ground Ahead of Market's Open

GNC Plummets, Mallinckrodt Regains Ground Ahead of Market's Open

Mallinckrodt Hit With $100M Fine for Squelching Rival to Infant Seizure Drug

Mallinckrodt Hit With $100M Fine for Squelching Rival to Infant Seizure Drug

Trump Administration Isn't ' Pulling the Rug

Trump Administration Isn't ' Pulling the Rug" from Anyone, Says HHS Pick Price

Allergan Rebounding With Strong Product Pipeline, Smart Acquisitions

Allergan Rebounding With Strong Product Pipeline, Smart Acquisitions

Health and Human Services Secretary Pick to Face Capitol Hill Grilling

Health and Human Services Secretary Pick to Face Capitol Hill Grilling

McKesson Agrees to $150M Settlement Over Drug Order Irregularities

McKesson Agrees to $150M Settlement Over Drug Order Irregularities

Biogen Resolves Multiple Sclerosis Drug Dispute

Biogen Resolves Multiple Sclerosis Drug Dispute

Lawmakers Look to Rep. Price to Fill in Blanks on Obamacare Repeal

Lawmakers Look to Rep. Price to Fill in Blanks on Obamacare Repeal